- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06575673
An Internet-based Dialectical Behaviour Therapy-informed Skills Training for Promoting Smoking Cessation and Improving Psychological Distress of Adult Smokers.
September 17, 2025 updated by: Ho Long Kwan, Chinese University of Hong Kong
Effect of an Internet-based Dialectical Behaviour Therapy-informed Skills Training for Promoting Smoking Cessation and Improving Psychological Distress of Smokers: A Pilot Randomised Controlled Trial
- To determine the feasibility, acceptability, and preliminary effects of an internet-based DBT-ST for promoting smoking abstinence/reduction and improving psychological distress/emotional regulation in adult smokers
- To explore the participants' experiences and perceptions (e.g., perceived benefits/weaknesses) towards the proposed intervention
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Long Kwan Ho, PhD
- Phone Number: 39430664
- Email: longkwanho@cuhk.edu.hk
Study Contact Backup
- Name: Hiu Nam Naomi Wu, Bachelor
- Phone Number: 39438167
- Email: hiunamnaomiwu@cuhk.edu.hk
Study Locations
-
-
-
Hong Kong, Hong Kong
- Not yet recruiting
- Hospital Authority
-
Contact:
- Long Kwan Ho
- Phone Number: 852-3943-0664
- Email: longkwanho@cuhk.edu.hk
-
Principal Investigator:
- Long Kwan Ho, Phd
-
-
New Territories
-
Tai Po, New Territories, Hong Kong
- Recruiting
- Hospital Authority
-
Contact:
- Long Kwan Ho
- Phone Number: 39430664
- Email: longkwanho@cuhk.edu.hk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Hong Kong Chinese aged 18-64 years
- Had smoked at least one cigarette per day over the previous three months
- Indicate psychological distress as measured by the Depression, Anxiety, and Stress Scale-21
- Have an intention to stop smoking
- Have an electronic device and are willing to receive interventions via the internet
Exclusion Criteria:
- Experiencing psychotic disorders/cognitive impairment/communication problems
- Participating in other smoking cessation programs or related psychosocial interventions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: DBT-ST group
Participants in the intervention group will receive the DBT-ST by means of a free video-communication app.
Over the next 14 weeks from the baseline, participants will receive two individual sessions (30-45 mins) and 12 group therapy sessions (120-minute)
|
Adaptive applications of DBT-ST for smokers with psychological distress
|
|
Other: TAU
Participants in the control group will receive a smoking cessation booklet published by the Hong Kong Council on Smoking and Health that provided information on the negative health consequences of smoking, reasons to quit, strategies for quitting, smoking cessation services available in Hong Kong, and a public Quitline number (usual care).
Participants will also receive a monthly health education for three months that provides general health information and sharing sessions, which is one of the routine care for smokers during the first 3-4 months after they seek help for smoking problem (waiting period for further intervention).
|
General health information and sharing sessions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Biochemically validated 7-day PPA (an exhaled CO test and a salivary cotinine test)
Time Frame: Baseline, 3-month post-intervention
|
Participants who self-reported not smoking within the past seven days will be invited to attend a biochemical verification test of smoking abstinence
|
Baseline, 3-month post-intervention
|
|
Level of psychological distress
Time Frame: Baseline, 3-month post-intervention
|
Symptoms of depression, anxiety and stress measured by the Chinese version of Depression, Anxiety, and Stress Scale-21
|
Baseline, 3-month post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported 7-day PPA
Time Frame: Baseline, 3-month post-intervention
|
Self-reporting of complete abstinence for at least seven days prior to assessment
|
Baseline, 3-month post-intervention
|
|
Self-reported smoking reduction of at least 50%
Time Frame: 3-month post-intervention
|
Participants will report the number of cigarette they consume and the number will be compared to the number at baseline
|
3-month post-intervention
|
|
Quit attempts
Time Frame: Baseline, 3-month post-intervention
|
The number of times that the participant engage in a period of intentional abstinence of more than 24 hours in the previous three months
|
Baseline, 3-month post-intervention
|
|
Emotion dysregulation
Time Frame: Baseline, 3-month post-intervention
|
Levels of emotion dysregulation measured by the Chinese version of the Difficulties in Emotion Regulation Scale (DERS)
|
Baseline, 3-month post-intervention
|
|
Distress tolerance
Time Frame: Baseline, 3-month post-intervention
|
Perceived ability to tolerate emotional distress measured by the Chinese version of the Distress Tolerance Scale (DTS)
|
Baseline, 3-month post-intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability
Time Frame: 3-month post-intervention
|
Client Satisfaction measured by the 8-item Client Satisfaction Questionnaire-8
|
3-month post-intervention
|
|
Feasibility of the intervention
Time Frame: 3-month post-intervention
|
Recruitment rate
|
3-month post-intervention
|
|
Feasibility of the intervention
Time Frame: 3-month post-intervention
|
Intervention engagement in terms of time spent on each session and participation rates
|
3-month post-intervention
|
|
Feasibility of the intervention
Time Frame: 3-month post-intervention
|
Attrition rates
|
3-month post-intervention
|
|
Semi-structured interview
Time Frame: 3-month post-intervention
|
Individual semi-structured interviews will be conducted at post-intervention to explore participants' experiences/perceptions of the internet-based DBT-ST, as well as their comments on the appropriateness/comprehensiveness of the content/frequency of the intervention.
|
3-month post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 4, 2024
Primary Completion (Estimated)
September 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
August 19, 2024
First Submitted That Met QC Criteria
August 26, 2024
First Posted (Actual)
August 28, 2024
Study Record Updates
Last Update Posted (Actual)
September 22, 2025
Last Update Submitted That Met QC Criteria
September 17, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 07210048
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
University GhentActive, not recruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Johns Hopkins UniversityNational Center for Advancing Translational Sciences (NCATS); Community Partnership...CompletedSmoking Cessation | Smoking Reduction | Smoking, TobaccoUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
-
Virginia Polytechnic Institute and State UniversityCompletedCigarette Smoking Behavior | Smoking Behaviors | CigaretteUnited States
Clinical Trials on Monthly health education
-
State University of New York at BuffaloActive, not recruitingType 2 DiabetesUnited States
-
Leiden University Medical CenterCompletedKnee Arthropathy | Quality Improvement | Hip Arthropathy | Registries | Hospital PerformanceNetherlands
-
Chinese University of Hong KongCompletedAlcohol DrinkingHong Kong
-
University of Sao Paulo General HospitalUnknown
-
Lundquist Institute for Biomedical Innovation at...PfizerWithdrawnArthritis, RheumatoidUnited States
-
Monash UniversityNovartis PharmaceuticalsTerminatedCerebrovascular Disease | Coronary Heart Disease (CHD) | Peripheral Arterial Disease (PAD) | Atherosclerotic Cardiovascular Disease (ASCVD)Australia
-
Federal University of PelotasActive, not recruiting
-
University of PretoriaUnknown
-
Ankara UniversityCompletedEducation | Fertility | YouthTurkey
-
Universiti Sains MalaysiaNot yet recruitingKnowledge, Attitudes, Practice | Early Childhood Caries